NP / PA
Dibiasio, Jeremy
Dibiasio, Jeremy was paid $737K by Medicaid between Oct 2021 and Dec 2024, across 18 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 26% of everything it billed.
33Billing provider infoDIBIASIO, JEREMY
WARWICK, RI 02889
WARWICK, RI 02889
33aNPI1114533783assigned 09/19/2020
33bProvider typeFamily Nurse Practitioner
28Total paid$737K
24GClaims9,453
24DCodes billed18
24AFirst – last monthOct 2021 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Rhode Island
Rank by total paid#4 of 266
Median peer was paid$31K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 900 | $69K | |
| 2022 | 3,432 | $272K | |
| 2023 | 2,913 | $233K | |
| 2024incomplete | 2,208 | $162K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 26% | 1,338 | 1,267 | $189K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 1,319 | 1,282 | $129K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13% | 690 | 681 | $93K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7.3% | 642 | 627 | $54K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.2% | 1,251 | 1,171 | $53K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.6% | 224 | 221 | $49K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.9% | 254 | 250 | $36K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.5% | 977 | 932 | $26K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.7% | 562 | 556 | $20K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.5% | 89 | 77 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 226 | 220 | $18K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.9% | 163 | 157 | $14K |
6 more codes
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.8% | 164 | $14K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 478 | $10K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 98 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 215 | $4K |
| 81025 | <1% | 223 | $3K | |
| 81002 | <1% | 540 | $3K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.